Stacey Seggelke, sees patients with diabetes both in and out of the hospital, and shared her experiences at the Kindred Clinical Impact Symposium. She is a member of the inpatient Glucose Management team at the University of Colorado Hospital and has an outpatient diabetes clinic one day per week.
There has been a steady and significant increase in diabetes over the last 30 years. It affects 8 percent of the population, and it is estimated that there are 79 million people who are pre-diabetic. Even when it is not the primary diagnosis, diabetes impacts the care provided to the person, and Seggelke works with her patients from admission to discharge to make sure that the treatments for other medical issues don’t harm the patient or cause problems related to their diabetes.
Did you know that a pharmacist invented Coca Cola? This was just one interesting fact divulged by Kindred Hospital Division Vice President of Pharmacy James Poullard, who presented this afternoon at Kindred’s Fifth Annual Clinical Impact Symposium.
For Coke lovers, this fact makes pharmacists critical. But more importantly, pharmacists play a crucial role in effective care transitions.
Pharmacy – the science and technique of preparing and dispensing drugs and medicines – has undergone a transformation over the years, according to Poullard.
“We’ve gone from pouring sodas and mixing elixirs to now being the medication expert in retail outlets, and in the inpatient arena,” he said. “There are now post-graduate residency programs and we’ve become an integral part of the patient care team.”
And pharmacists have their work cut out for them.
Representatives from each of Kindred’s divisions – the Hospital Division, the Nursing Center Division, Kindred at Home, RehabCare and the Care Management Division – demonstrated ways in which Kindred clinicians and staff across the enterprise can collaborate to improve care transitions throughout the country during a presentation at the Fifth Annual Clinical Impact Symposium.
Kindred Clinical Impact Symposium speaker Dr. Eric Coleman challenged attendees at the event to step out of their comfort zones to really look at what it means to say, “We are patient-centered” or “We are involved in patient engagement.”
The key is to focus on what patients want for themselves, not just on what providers want for them, he said. Caregiver involvement is also vital.
Dr. Coleman is the founding director of The Care Transitions Program, a national program that aims to improve quality and safety at times of transition across settings for patients. This is his second year speaking at the symposium.
Kindred Chief Executive Officer Paul J. Diaz and President and Chief Operating Officer Benjamin A. Breier addressed participants at Kindred’s Fifth Annual Clinical Impact Symposium by painting a portrait of where Kindred is now, and where the company is going over the next several years, as the American healthcare landscape continues to change.
“We are seeing rapid change in the way healthcare is delivered in this country,” said Diaz. Delivering high quality, low-cost care, reducing rehospitalizations and adapting to new payment models that focus on a patient’s entire episode of care are the orders of the day.
As the nation’s largest diversified provider of post-acute care services, Kindred, which cared for over half a million patients last year alone, is well-positioned to meet these challenges.
Diaz outlined Kindred’s three general goals:
Speakers from divisions of Kindred Healthcare urged attendees of the 2013 Kindred Clinical Impact Symposium to forge closer relationships at the event and work together to shape Kindred’s future.
Steven Monaghan, President of Kindred’s Hospital Division, opened his remarks by thanking the clinicians for their service and asking his team to stand for recognition. From his perspective, they are on the front line to deliver the Kindred message of hope, healing and recovery directly to patients and their families. He issued a challenge to all attendees to think about what each can do to help design the future of Kindred.
The fifth annual Kindred Clinical Impact Symposium is officially underway! This year’s symposium, “Clinical Excellence in Care Transitions and Disease Management: Managing Diabetes, Infections and Cognition Across the Continuum” will run today through Thursday at the Marriott Hotel in downtown Louisville.
Senior Vice President of Clinical Operations of the Hospital Division Tony Disser welcomed participants to the “most exciting few days in care transitions” at Kindred Healthcare with an apology for the cold and snowy weather. Official Kentucky Derby bugler played “My Old Kentucky Home” and the call to post, a Clinical Impact Symposium traditional treat.
The Fifth Annual Kindred Clinical Impact Symposium, “Clinical Excellence in Care Transitions and Disease Management: Managing Diabetes, Infections and Cognition Across the Continuum,” is being held in Louisville this week, November 11-14, 2013.
This year’s symposium will offer the latest evidence-based information from some of the most widely respected experts in the nation as well as interactive break-out sessions, hands-on skills demonstrations and a poster session and trade show exhibits.
The audience for the symposium is made up of caregivers and leadership from across the Kindred enterprise, including the Hospital Division, Nursing Center Division, RehabCare, the Care Management Division and Kindred at Home. The goal is to enhance clinical practice across the post-acute continuum and maintain Kindred as a leader in clinical excellence.
Speakers at the symposium will include:
The learning curve is in full swing one month into Obamacare, as those who stand to gain coverage, those who stand to lose coverage and those who are wondering if their coverage will change begin to grasp the answers to their questions. Read the story
Creation of a new payment system aimed at reducing healthcare costs depends on physician engagement, according to a new report that features the opinions of 18 physicians interviewed by the Robert Wood Johnson Foundation. Read the story
As we learn more about the pathophysiology of diabetes mellitus, we find that there is more yet to be discovered. Diabetes mellitus is a syndrome with disordered metabolism and inappropriate hyperglycemia due to either a deficiency of insulin secretion or to a combination of insulin resistance and inadequate insulin secretion to compensate. Type 1 diabetes is due to pancreatic islet B cell destruction predominantly by an autoimmune process, and these persons are prone to ketoacidosis. While type 2 diabetes is the more prevalent form and results from insulin resistance with a defect in compensatory insulin secretion. Diabetes can lead to serious complications, resulting in multiple diseases or disorders that affect multiple systems that may result in premature death.
[caption id="attachment_2695" align="alignright" width="300"] Image from www.drugs.com.[/caption]
Kindred Healthcare680 South Fourth StreetLouisville, KY 40202Phone: 502.596.7300Toll Free: 1.800.545.0749
Copyright © 2014 Kindred Healthcare, Inc., EOE